Table 2.
Procedural and 30-Day Outcomes.
| Nonsignificant MR (n = 65) |
Significant MR (n = 55) |
P value | |
|---|---|---|---|
| Procedural variables | |||
| Prosthesis size ≤ 24 mm | 33 (50.8) | 29 (52.7) | 0.606 |
| Access routes | |||
| Transfemoral | 47 (72.3) | 41(74.5) | 0.612 |
| Nontransfemoral | 18 (27.7) | 14 (25.5) | 0.784 |
| Post-procedural variables | |||
| Acute kidney injury requiring dialysis | 5 (7.7) | 10 (18.2) | 0.022 |
| Disabling stroke | 2 (3.1) | 2 (3.6) | 0.191 |
| New permanent pacemaker | 3 (4.6) | 3 (5.5) | 0.321 |
| Length of hospital stay (days) | 5.8 ± 2.2 | 7.3 ± 2.5 | 0.023 |
| 2-valve implantation | 2 (3.1) | 3 (5.5) | 0.663 |
| Major vascular complication | 1 (1.5) | 1 (1.8) | 0.534 |
| Coronary occlusion | 0 | 0 | – |
| Myocardial infarction | 0 | 0 | – |
| Major bleeding | 0 | 0 | – |
| Post-procedural echocardiography | |||
| Mean aortic gradient (mmHg) | 8.9 ± 4.2 | 8.5 ± 4.7 | 0.899 |
| Aortic valve area (cm2) | 1.65 ± 0.58 | 1.62 ± 0.59 | 0.827 |
| Residual moderate to severe AR | 3 (4.6) | 6 (11.0) | 0.006 |
| 30-day outcomes | |||
| All-cause mortality | 1 (1.5) | 1 (1.8) | 0.542 |
| Cardiovascular mortality | 0 | 0 | – |
Values are expressed as mean ± standard deviation or number (%). MR, mitral regurgitation; AR, aortic regurgitation.